Jinxin Fertility Group Limited (“JXR”) reported a fresh share repurchase on 2 July 2026, buying back 2.45 million ordinary shares on the Hong Kong Stock Exchange at prices between HK$2.00 and HK$2.04 per share. The transaction cost totalled HK$4.94 million, implying an average price of approximately HK$2.02 per share.

Including this latest purchase, JXR has acquired 6.41 million shares since shareholders renewed the company’s repurchase mandate on 25 June 2026. This represents 0.24% of the 2.71 billion shares outstanding on the mandate date and utilises about 2.44% of the 262.51 million-share limit authorised by shareholders.

Across all buybacks executed but not yet cancelled between 27 March and 2 July 2026, the company has accumulated 86.34 million shares for cancellation, equal to roughly 3.19% of its current issued share base of 2.71 billion shares. As at 2 July 2026, the number of issued shares on record remains unchanged at 2.71 billion, with no treasury shares held.

In line with Hong Kong listing rules, JXR is subject to a moratorium on issuing new shares or transferring any treasury shares until 1 August 2026. The company confirmed that all repurchases complied with the requirements of the Hong Kong Stock Exchange and the accompanying explanatory statement dated 2 June 2026.